The EXIT-TB project is part of the EDCTP2 programme supported by the European Union.                              

Translation research into policy and practice: Scaling up Evidence Based Multiple Focus Integrated Intensified Tuberculosis (TB) Screening to End TB in the East African region. This multi-center implementation study aligns with the diagnostics platform of CDT-Africa. The project aims to improve detection of TB through integrated and intensified TB Screening package. In addition to Ethiopia, the project is implemented on four African countries: Tanzania, Kenya, Uganda, and Sudan. The intervention package is implemented on four urban and three rural facilities in each participating country.  Expected outcomes of the project include increased TB case detection, reduced TB diagnostic and treatment delays, and increased number of TB patients put into TB care including women and children. CDT-Africa is a TB node, and will work to be a center of excellence for the diagnosis and treatment of TB. The European and Developing Countries Clinical Trials Partnership (EDCTP) funds the project with €2,957,924.09 for a total duration of 36 months.